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ABSTRACT 
 
Comparing health outcomes and primary care physician utilization among low-income 




Background: Care management programs aim to improve individual health outcomes by using 
care managers to assist with the integration of heterogeneous health care and social service 
components. Project Access of Durham County (PADC) and Local Access to Coordinated 
Healthcare (LATCH) administer a care management program to an uninsured and racially diverse 
population in Durham, North Carolina. This population experiences substantial disparities in type 
2 diabetes and hypertension prevalence and secondary complications. PADC-LATCH administers 
this program through standard (SCM) and intensive (ICM) protocols. The intensive protocol 
consists of more frequent and comprehensive individual encounters and is reserved for individuals 
meeting specific criteria with respect to chronic disease diagnoses and/or uncontrolled chronic 
disease. This evaluation investigates baseline patient characteristics among the protocols, if each 
is being implemented appropriately, and the effect on clinical outcomes.  
Methods: Individuals having a recorded diagnosis of type 2 diabetes and/or hypertension and who 
were enrolled and receiving care management under the SCM (n=123) or ICM (n=23) protocols 
between January 1, 2015 and June 30, 2015 were considered in the final evaluation. Individual 
data were abstracted from care management notes and medical records. Data analysis was 
performed to investigate outcome changes within and across each group. 
Results: Mean age (ICM: 51.9 years ± 8.63, SCM: 51.2 years ± 10.4, P=0.78), baseline systolic 
(P=0.69), and diastolic blood pressure (P=0.078) were similar for both groups while baseline 
hemoglobin A1c differed significantly (P<0.05). Those enrolled in ICM experienced a reduction 
in HbA1c from 10.6 to 9.51% (P=0.1), an 8.76% decrease, compared to individuals in SCM who 
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had a small increase in HbA1c from 6.73 to 6.78% (P=0.92), a 2.03% increase. The difference in 
percent change in HbA1c across groups was not statistically significant (P=0.09). Both groups saw 
non-significant reductions in both systolic (ICM: 141.6 ± 19.1 to 137.2 ± 18.6, P=0.17 and SCM: 
143.5 ± 21.2 to 140.6 ± 18.9, P=0.19) and diastolic blood pressure values (ICM: 81.5 ± 11.2 to 
79.8 ± 12.1, P=0.60 and SCM: 85.8 ± 10.8 to 84.5 ± 10.6, P=0.23). There was no statistically 
significant difference in percent change in systolic (P=0.46) and diastolic blood pressure values 
(P=0.99) across groups. Those receiving SCM had a statistically significant reduction in the 
proportion of PCP visits with a decrease of 16.7% (P<0.05) compared to a decrease of 0.8% 
(P=0.25) among individuals receiving ICM, with no significant difference between groups 
(P=0.39). Lastly, only 57.1% of ICM individuals achieved their care management goals compared 
to 78.2% of those enrolled in SCM (P<0.05). 
Conclusions: SCM and ICM protocols have varying results on outcomes of interest. Those 
enrolled in SCM saw a unexpected decrease in PCP utilization and achieved care management 
goals at a higher rate than counterparts receiving ICM. Individuals enrolled in the ICM protocol 
saw a decrease in HbA1c. Effects on blood pressure values were equivocal. This evaluation 
suggests that each protocol achieves desired results to varying degrees. As such, there should be 












  3 
OVERVIEW 
 Chronic disease is highly prevalent among racial minorities in the United States and those 
living in poverty. This paper aims to evaluate the effects of the standard and intensive 
components of a care management program among a low-income, racially diverse population 
with diagnoses of type 2 diabetes mellitus (type 2 DM), hypertension, or both. The effects on 
health outcomes and primary care physician (PCP) utilization will be the focus, with attention 
given to additional secondary outcomes. The care management program is administered by 
Project Access of Durham County (PADC) and Local Access to Coordinated Healthcare 
(LATCH). This evaluation of the care management program was solicited by PADC program 
directors and supported by PADC evaluation staff. The evaluation was conducted by a medical 
student evaluator.  
In the next section of this paper I will discuss the prevalence of type 2 DM and 
hypertension in the general U.S. population, racial minorities, and the poor. I will then discuss 
care management theory along with various chronic disease care management approaches that 
have emerged over the last two decades, focusing on care management approaches that most 
closely resemble the PADC-LATCH care management program. Then I will present the methods 
used in this analysis of care management program data along with the results of the analysis and 
a discussion of those results. The appendices at the end of this paper that reflect data presented in 
this paper. It was my hypothesis that this analysis of the PADC-LATCH care management 
programs would show no effect on patient health outcomes or patient utilization of their PCPs. 
BACKGROUND 
Type 2 DM and hypertension prevalence 
It is well-established that type 2 DM and hypertension are health problems in both the 
United States and North Carolina. Recent statistics show a continued year-over-year increase in 
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diabetes prevalence for the past several decades, and intermittent periods of growth and 
stagnation with overall increased prevalence for hypertension, as shown in Table 1 (Appendix 
A).1,2 In 2014, Type 2 DM had a prevalence of 12.3% and prediabetes prevalence was at 37% 
among all adults in the United States.3 Prevalence of diabetes has nearly doubled from a 6.2% 
prevalence during the period between 1988 and 1994.4 The prevalence of hypertension for adults 
in the United States was 29.0%, over a 3-year interval (2011-2014). Of those adults with 
hypertension, 47.0% had uncontrolled hypertension.5 However, since 1999, there has been a 
stagnation (range 28.4%-29.9%) in hypertension prevalence with a gradual increase in the 
proportion of adults having controlled hypertension, increasing from 31.5% in 1999 to 54.0% in 
2014.5  
The burden of these diseases is similar in North Carolina to that of the country overall. In 
2014 statewide prevalence was 35.5% for hypertension and 10.8% for diabetes.6  
High prevalence of these diseases coupled with their high burden of morbidity and 
mortality make these diseases urgent matters.3,7 Advanced type 2 DM is associated with micro- 
and macrovascular complications that are manifested as retinopathy, nephropathy, neuropathy, 
cerebrovascular accidents, and myocardial infarction.3 Advanced hypertension places patients at 
risk for cerebrovascular accidents, myocardial infarction, and congestive heart failure. Death is 
also a possible complication of both diseases. The attributable death rate for hypertension rose 
13.2% from 2001 to 2011 to 18.9/100,000 deaths, while the death rate attributable to type 2 DM 
stood at 21.7/100000 deaths in 2011.1 
Disproportionate burden of disease among racial and ethnic minorities  
As shown in the Table in Appendix A, there is a differing prevalence of these diseases 
among racial and ethnic groups in the U.S. Over a 3-year interval (2010-2012), the prevalence of 
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diabetes was shown to be disparate across race and ethnicity with a prevalence of 13.2% in non-
Hispanic black adults and 12.8% in Hispanic adults compared to 7.6% among white adults.3  
Hypertension statistics reveal a similar disparity across racial/ethnic lines with a 
prevalence of 41.2% among non-Hispanic black adults compared to 28.0% among non-Hispanic 
white adults, but only 25.9% among Hispanic adults. The lower prevalence of hypertension 
among Hispanic adults differs from the expected prevalence based on ethnicity. However, non-
Hispanic black adults and Hispanic adults had a higher prevalence of uncontrolled hypertension 
compared to their white counterparts.5   
The disparities across race and ethnicity are also present in the rates of complications 
from these diseases, with black adults regularly suffering complications at higher rates. The 
incidence of end-stage renal disease associated with diabetes is sharply higher for black adults 
(461.7/100 000 people) than either Hispanic and white adults.8 Visual complications among 
adults with diabetes is higher in black adults (20.7%) and white adults (17.1%) than Hispanic 
adults.9 Only with cardiovascular disease complications do white adults (33.9%) have a slightly 
higher rate of complications than their black (33.0%) and Hispanic (24.5%) counterparts.10  
These racial disparities are also reflected in higher mortality rates. Mortality rates among 
diabetics were highest among black males (44.9/100 000 deaths) and black females (35.8/100 
000 deaths) compared to white males (24.3/100 000 deaths).1 As with type 2 DM mortality rates, 
the mortality rates associated with hypertension are disproportionate across race with rates at 
47.1/100 000 deaths for black males compared to 17.6/100 000 deaths for white males.1 
Poverty 
A disproportionate disease burden also exists among those who are poor. Individuals with 
family income below the poverty level were found to have 2 times the risk of mortality from 
  6 
diabetes compared to individuals from families with higher incomes.11 In regards to 
hypertension, poorer individuals had only a modest increase in their risk of developing the 
disease compared to wealthier individuals. However, poorer individuals were 2 to 3 times more 
likely to have a myocardial infarction or stroke.12 
Ethnic minorities are more likely than white Americans to be poor. A 2014 U.S. Census 
report found that 26.2% of black adults and 23.6% of Hispanic adults live below the poverty line 
compared to 10.6% of non-Hispanic whites.13 Ethnic minorities then face a greater burden of 
both chronic disease and poverty in the U.S. compared to their counterparts. The reasons behind 
this racial and income-based increased risk in disease are multifactorial and spans social, 
cultural, and genetic disciplines.  
Some factors behind this increased burden are poverty, daily stressors, language barriers, 
and neighborhood environment. A lack of sufficient income precludes many minority 
populations from regular access to healthcare and when there is access there is a persistent lag in 
quality.14,15 Inadequate self-management behaviors and spotty access to appropriate medications 
cause further issues with disease control.14 Stress has also been associated with a higher 
prevalence of both type 2 diabetes and hypertension along with a higher risk of morbidity in 
Hispanics.16 Low English proficiency among low-income Hispanics increased the likelihood of 
poor diabetes self-management.17 Lastly, as mentioned earlier, both Hispanic and African 
Americans more likely than whites to be poor and as such are more likely to live in poorer 
neighborhoods. A higher prevalence of diabetes and hypertension has been found among people 
living in neighborhoods with low socioeconomic levels.18 This combination of factors leads to a 
large disease burden placed upon the racial minority communities of the U.S. 
Chronic disease care management theory 
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Care management programs (CMPs) are an approach to potentially improving health 
outcomes in patients with chronic disease.19 It is believed that chronic disease care management 
programs have their origins in the contingency theory of Lawrence and Lorsch. The theory 
stresses the need for integration and collaboration of many parts of a system in response to the 
needs of the environment.20 Walter Leutz applied this theory to health care and noted the need to 
integrate health care systems and social service systems to improve health outcomes.21Responses 
to varying environments and needs result in heterogeneous programs with differing 
components.20 However, CMPs regularly coordinate health and social services for individual 
patients and are carried out by interdisciplinary teams consisting of a blend from among 
physicians, pharmacists, nurses, health educators, and community health workers.22,23 
Approaches to chronic disease care management  
 Care management programs have taken on many forms within the U.S. and abroad. One 
study highlighted a case management program in which nurses followed management algorithms 
under the supervision of physicians within a health maintenance organization.24 Another study 
investigated the effect of country-wide, voluntary type 2 DM disease management programs 
within the German health care system.25 A nurse-led care management program focused on 
reducing cardiovascular morbidity in patients with hypertension through an e-mail reminder 
program 26, while another nurse-led care management intervention focused on motivational 
interviewing.27 Lastly, there are some examples of pharmacist-based hypertension care 
management programs in the literature.28 
Care management protocols 
Because of the variety of CMP models, we will focus our discussion of previous research 
on models that are most similar to the care management program under study here. The care 
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management program in question is based out of Durham, North Carolina and is affiliated with a 
local academic hospital. Durham County, North Carolina has a population of 294,000.29 The 
program is coordinated and administered by the Project Access of Durham County (PADC) and 
Local Access to Coordinated Health Care (LATCH) in Durham, North Carolina. Eligible patients 
are placed in either the standard care management (SCM) or the intensive care management 
(ICM) protocol depending on the reason they are referred to the program. 
The program protocol is initiated with the referral of patients needing specialty care to the 
PADC program. Primary care providers at Lincoln Community Health Center in Durham, North 
Carolina, a local Federally Qualified Health Center, or one of its satellite clinics issues these 
referrals. The referrals are evaluated for eligibility by PADC staff. Eligible patients must be 
Durham county residents, uninsured, and have household income less than 200% FPL. Eligible 
patients who enroll have access to specialty care services for one year. 
All PADC patients are then enrolled in LATCH.  Patients who are designated as needing 
a specialty care appointment but not meeting any of the criteria listed for ICM, are placed in 
SCM. Patients meeting any of the following criteria will be enrolled in the ICM protocol: 1.) 
needing to consult with a specialist for their chronic disease, 2.) out-of-control chronic disease 
being a barrier to treatment, or 3.) significant psychosocial issues creating barriers to treatment. 
The following chronic diseases are targeted by the ICM protocol: type 1 or 2 DM, hypertension, 
hyperlipidemia, asthma and/or chronic obstructive pulmonary disease, and/or congestive heart 
failure. 
Standard care management 
  9 
 Each protocol contains unique components. SCM is visualized in Figure 1 (Appendix B).  
For SCM, either a nurse care manager (NCM) or a health education specialist (HES) helps 
patients needing specialty care in two phases pertaining to the specialty care appointment.  
Pre-appointment preparation includes either a telephone encounter or home visit, at least 
2 weeks in advance of specialty care appointment to: coordinate appointments, discuss and 
navigate appointment logistics (e.g. pre-appointment labs or procedures), arrange transportation 
through PADC, provide interpretation services at specialty care appointments, address barriers to 
accessing care or managing their treatment plan. 
SCM post-specialty appointment contact will be made by either telephone encounter or 
home visit one week after the appointment. This encounter will include: addressing patient 
concerns, checking on patient’s status, referring patient to PCP for any follow-up questions or 
medication needs, provide medication management as appropriate, assist with medication, assist 
with durable medical equipment (DME), provide appropriate psychosocial support resources, 
provide translation of treatment plan, provide assistance with follow-through of treatment plan, 
and follow-up on patients who miss appointments.  
Intensive care management  
The ICM protocol is shown in Figure 2 (Appendix B).  As with SCM, patients enrolled in 
ICM are managed by either an HES or NCM. Initial telephone contact by the care managers is 
made between 5-10 days after the date of referral. This initial contact serves as an assessment of 
the complexity of the patient’s situation, knowledge of disease, and current self-management 
strategies. Home visits are completed as determined by the NCM or HES. Each home visit 
consists of: patient education, review of medications and any barriers, setting self-management 
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goals (with a follow-up of 30 days), referral to PCP, assessment of additional barriers to care, 
and referral to appropriate psychosocial and community resources.  
Each patient is contacted or visited prior to each medical appointment, after each 
appointment, every 2 weeks for 6 weeks after initial referral date, and 3 months after initial 
referral date. The number of encounters therefore varies, but at minimum will be three, except in 
cases in which the patient is lost to contact. The nature of each encounter is tailored based on the 
patient’s needs, but generally includes the activities listed above.  
Literature review (refer to Figures 3-5 and Tables 2-6 in Appendix C) 
There is a relative abundance of literature that addresses the effectiveness of care 
management programs on clinical outcomes. However, a review of the available literature shows 
there are few articles that reflect the nature of the LATCH-PADC care management program and 
the population it serves. The programs in the literature are implemented by personnel other than 
nurses or health educators, do not focus on a largely uninsured and low-income population, 
and/or do not investigate clinical outcomes. This review, requested by the PADC evaluation 
team, covers the articles most relevant to the LATCH-PADC care management program.  
  Kim et al. (2014) investigated a nurse-led community-based case management (CBCM) 
program for patients with hypertension via a prospective cohort study. The intervention consisted 
of a needs assessment for the patient followed by a prioritization of problems followed by case 
management to address the prioritized issues. Case management was administered through 6 
phone encounters and 2 home visits over a duration of 2-8 months, based on each patient’s blood 
pressure control. The patient population was a specifically low-income population and largely 
older (85% older than 65 years of age). It was found that both pre/post systolic and diastolic 
blood pressure levels decreased significantly after enrollment in the CBCM program, along with 
  11 
increased hypertension knowledge and hypertension self-management ability. Despite the results 
supporting the use of care management programs, this study had a limited external validity due 
to its uneven patient characteristics (86.4% were older than 65; 77.3% were female) and 
additional potential sources of bias from the lack of blinding of patients and personnel, its small 
sample size, and the lack of a control group (other than the patients themselves).30 
A retrospective study by Sekhobo et al. (2008) investigated the effects of a case manager-
led chronic disease case management program for patients diagnosed with type 2 DM receiving 
care at community health centers. Case managers were responsible for delivering diabetes 
education and self-management approaches along with connecting patients with appropriate 
resources and ensuring continuity of care. The frequency of case manager encounters was not 
explicitly stated, but each patient had care management for at least one year. It was found that 
both systolic and diastolic blood pressure levels decreased significantly after enrollment in the 
CBCM program, along with hypertension knowledge and hypertension self-management ability.       
 Results showed improvement in HbA1c control by patients entering the program with 
intermediate or poor baseline glycemic control. The largest improvements in HbA1c were made 
by patients with the poorest glycemic control at baseline. Another analysis showed that there was 
a statistically significant difference in glycemic control for patients enrolled in case management 
compared to those not receiving case management. This study maintained a low risk of bias, but 
the small control group sample size and the lack of outcome assessor blinding created some 
concern for overestimation of program effect. However, the low magnitude of these 
shortcomings paired with the remaining study characteristics reduced the potential for bias. 31 
 The California Medi-Cal Type 2 Diabetes Study Group (2004) produced a randomized 
controlled study on a team-based intensive diabetes case management program for low-income 
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patients with type 2 DM. Case management consisted of four components: 1.) following 
evidence-based guidelines in diabetes medication, 2.) identifying and creating plans to overcome 
barriers to care, 3.) education on proper glucometer use, and 4.) education on diabetes self-
management including diet and exercise education. The program was administered on an “as 
needed” basis with no guidelines noted for case management administration nor for the duration 
of the intervention.  
There was statistically and clinically significant improvement in HbA1c at all points of 
follow-up in the intervention group compared to the control group. Although the control group 
still experienced improved HbA1c levels, it was not by the same magnitude experienced by the 
intervention group.  The intervention group also experienced a decrease in systolic blood 
pressure, whereas the control group stayed stagnant, and a significant decrease in diastolic blood 
pressure. As a randomized, controlled study, there was an overall low risk of bias, however there 
was no blinding of participants, personnel, and outcome assessors creating a high potential for 
both performance and detection bias, and overestimation of the effect of the intervention. 
However, the remaining characteristics of the study lowered the overall risk of bias for the 
study.32 
 Hebert et al. (2012) investigated a nurse management intervention on patients with 
hypertension living in Harlem, New York. The article describes a randomized, controlled study 
that took place at 5 sites across Harlem, including one Federally Qualified Health Center. The 
patients in this study were not explicitly low-income or uninsured, but eligibility criteria required 
that patients were either Hispanic or black. The study setting, clinical sites, and ethnic and racial 
makeup of the recruited patient sample indicate that the patient were more likely to be of a low-
income background. This intervention consisted of multiple components, including: 1.) in-person 
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self-management counseling, 2.) smoking and alcohol reduction counseling, 3.) regular 
telephonic follow-up, and 4.) frequent nurse-physician communication and adaptation on patient 
treatment plans.  There was no clearly stated guide to the number of encounters expected to be 
administered to each patient, but telephonic care management was delivered for a duration of 9 
months.  
This study showed that patients enrolled in the nurse management arm of the study had 
statistically significant decrease in systolic blood pressure at 9-month follow-up and a continued, 
but non-significant decrease at the 18-month follow-up. Results also showed that patients in the 
other two groups, the home BP monitor and usual care groups, had non-significant decreases in 
systolic and diastolic blood pressure at both follow-up time points. Despite the fact that this 
study was a randomized, controlled study, there was a high risk of bias due to the unorthodox 
recruitment strategy that was used. The study had begun with 2 study arms, but was increased to 
3 study arms after additional funding was secured. This created issues with matching study 
groups demographically and although the issue was discussed and controls were matched 
contemporaneously, there is concern that patients recruited earlier in the study were able to be 
randomized to the home BP monitor group, leading to a potential for selection bias. 33 
 Philis-Tsimakas et al. (2004) is the last study that was reviewed. This was a prospective 
cohort study that investigated the effects of a nurse-led care management program paired with a 
peer education component on HbA1c in patients with diagnosed type 2 DM. This study explicitly 
recruited patients belonging to one of three low-income payer groups: Medi-Cal, Medically 
Indigent Adult (MIA) health services program, or uninsured and income under the appropriate 
federal poverty level. The intervention duration was over 2 years and consisted of a minimum of 
4 visits in a calendar year, with an initial 2-hour assessment visit with subsequent clinic visits 
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being used to review treatment guidelines, medication changes, self-management techniques, and 
care management goals.  
The intervention group showed statistically significant decreases in HbA1c and diastolic 
blood pressure and a non-significant decrease in systolic blood pressure. The control group also 
exhibited a decrease in HbA1c, but to a lesser degree compared to the intervention group.  
Overall, this study had too many sources of potential bias stemming from a lack of 
randomization, high attrition rate, and no blinding of patients, personnel, or outcome assessors. 
Despite the high potential for an overestimation of the effect of the intervention due to potential 
biases, the results still reflect decreases in HbA1c and blood pressure. 34  
 These studies most closely reflected the program being evaluated in this paper. The 
results are positive in showing an overall improvement in HbA1c and blood pressure for patients 
with diabetes and/or hypertension enrolled in various nurse and/or care manager-led care 
management programs. There was no apparent relationship between the amount of care 
encounters received and effects on health outcomes. Only 2 of the 5 included studies (Kim et al. 
(2014) and Philis-Tsimakas et al. (2004)) had a prescribed minimum number of encounters and 
the remaining studies were administered as-needed and each had a significant reduction in their 
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METHODS 
Study overview 
A secondary data analysis was conducted to evaluate the ability of the PADC-LATCH 
intensive care management program to improve HbA1c, blood pressure, and other secondary 
outcomes in their designated patient population. This analysis was approved by the institutional 
review board of the Duke University Health System.  Research questions for the evaluation 
included: 
i.)  What do the data indicate about how well the protocol is being implemented? 
Specifically, do patients designated for ICM show greater clinical need than those designated 
for SCM?  
ii.)  Are patients designated for ICM in actuality receiving a greater volume of care than 
those designated for SCM?  
iii.)  How did clinical outcomes and PCP utilization change for each care management 
group? 
iv.)  How often did participants meet their behavioral goals? 
v.)  Was there a difference in outcomes for those receiving standard versus intensive care 
management? 
Study sample 
Patients eligible for inclusion in the analysis were 1.) active in the PADC-LATCH care 
management program (either standard or intensive program) between January 1, 2015 and June 
30, 2015, 2.) had a clinical diagnosis of type 2 diabetes, hypertension, or both, confirmed by 
inclusion in the patient’s problem list or being listed as a diagnosis in a clinical progress note 
created between January 1, 2015 and June 30, 2015, 3.) an age of 18 years or older at time of 
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participation in the program. Patients were excluded if they did not meet the eligibility criteria 
listed above or if they were missing data in all three key variables of HbA1c, blood pressure, and 
PCP visits.  
 A total of 425 patients were initially eligible based on activity in the program during the 
active dates. This population was reduced as filters were applied to the electronic health record 
(EHR) data gathering interface to include patients with valid diagnoses. A total of 168 patients 
who were listed on the hospital’s internal Chronic Disease Registry for type 2 diabetes, 
hypertension, or both remained eligible for participation. After chart review was completed for 
each patient, 1 patient was excluded for being underage, 1 for insufficient data, 4 for having no 
record in the care management database, and 16 for having no confirmed diagnosis in their 
records. There were 146 patients included in the final analysis, as shown in Figure 6 (Appendix 
D). 
Data sources 
Data for this analysis were obtained from PADC, LATCH, and the affiliated academic 
center electronic health record system. PADC and LATCH provided care management encounter 
data. The EHR provided clinical data. The local Federally Qualified Health Center pharmacy 
provided data on patient medication adherence.  
Variables 
 
Patient characteristics  
 Patient characteristics were collected from medical records and these data were grouped 
based on the care management protocol each patient received.  
Care management encounters 
Care management encounters were included in this analysis if they were classified in one 
of the following categories in the COACH database: Phone [Patient], Home Visit [Patient], 
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Community Encounter [Patient], or Practice Encounter [Patient]. Encounters were separated as 
phone encounters, home encounters, or community/practice encounters. Only encounters 
occurring after within 4 months after each PADC’s program participants start date were 
recorded. Four months was the chosen duration of time given that the ICM protocol lasts for 3 
months and it takes 1-15 days for an NCM or HES to make initial contact with a patient. 
Hemoglobin A1c 
Baseline HbA1c was defined as any HbA1c value calculated from a specimen collected 
between 7/1/13-12/31/14. If an A1c value was not available for this time period, an A1c value 
between 1/1/15-6/30/15 was recorded. This allowed for sufficient data to be gathered given that 
this analysis is retrospective and could not influence when data was gathered. Follow-up HbA1c 
was defined as any value calculated from a specimen collected between 7/1/15-5/30/16. If an 
A1c value was not available for this time period, an A1c value between 1/1/15-6/30/15 was 
recorded. For any individual, baseline and follow-up A1c values were separated by at least 3 
months. 
Systolic and diastolic blood pressure 
Baseline systolic and diastolic blood pressures were defined as the average of 3 readings 
calculated from consecutive blood pressure readings taken between 7/1/13-12/31/14. If a 
sufficient number of readings were not available for this time period, readings between 1/1/15-
6/30/15 were used in calculating the 3-value average. Follow-up systolic and diastolic blood 
pressures were defined as the average of at 3 readings calculated from blood pressure readings 
taken between 7/1/15-5/30/16. If a sufficient number of readings were not available for this time 
period, readings between 1/1/15-6/30/15 were used in calculating the 3-value average. In 
instances where there was more than 1 reading in a given visit (e.g. hospital admission, repeat 
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BP measurement at same office visit), the pair of values with the highest systolic value was 
recorded to have the estimate lean towards the null hypothesis.  
For an individual, any baseline and follow-up blood pressure readings used in calculating 
the 3-value average were separated by at least 1 month. Patients were included in the analysis if 
they had at least one reading in either category. 
Primary care physician utilization 
 Baseline quantity of PCP encounters was determined by number of encounters within the 
6-month period immediately preceding each participants’ program start date. Follow-up quantity 
of PCP encounters was determined by the number of encounters within the 6-month period with 
the first day of this period commencing 4 months after each participants’ program start date. For 
example, if patient X’s start program start date is 1/1/15, then the baseline period runs from 
7/1/14-12/31/15 and the follow-up period runs between 5/1/15-11/1/15. Data were presented as 
the median number of PCP encounters. 
 PCP encounters were classified as office visits with a primary care physician. Nurse only 
visits, lab visits, telephone calls, emergency department visits, urgent care visits, or specialists 
were not included in the PCP encounter count.   
Care management goal achievement 
 
Care management goals, if established, were classified as either achieved (100% 
completed) or not achieved (<100% completed) based on qualitative encounter data.  
Difference in dependent variables among SCM and ICM groups 
Statistical comparisons were made between the group means for HbA1c, blood pressure, 
PCP utilization, and goal achievement.  
Statistical Analysis 
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All analyses were performed using Stata SE v.14 (College Station, TX). The outcome 
assessor was not masked to patient diagnoses or care management grouping. The normality of all 
data was assessed using the Shapiro-Wilk test in conjunction with visual representations of the 
data. An alpha level of 0.05 was used as the metric for statistical significance. 
Patient characteristics 
Patient characteristics were calculated for each care management group. Means and 
standard deviations were obtained for continuous variables. Proportions were obtained for each 
categorical variable.  T-tests and chi-squared tests were performed to compare the characteristics 
of the SCM and ICM groups.   
Care management encounters 
 Care encounter counts were obtained via chart reviews. Due to non-normality, medians 
and interquartile ranges were obtained for each type of care encounter. Group medians were 
compared using the Wilcoxon rank-sum test.   
Diabetes control, hypertension control, PCP utilization, and care management goals 
HbA1c served as a surrogate for type 2 DM control, while systolic and diastolic blood 
pressure were used to reflect hypertension control. Pre- and post-intervention HbA1c, systolic 
pressure, diastolic pressure, and PCP visits were analyzed within each group using paired t-tests 
(which produced a t-statistic) or nonparametric Wilcoxon signed-rank test (which produced a z-
statistic), according to the normality of the data.  
Repeated measures one-way analysis of variance (ANOVA) (which produced an F-
statistic) was used to determine within-subject effects on HbA1c, blood pressure values, and PCP 
utilization. To fulfill the assumptions associated with the repeated measures one-way ANOVA, 
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outliers were removed, normality was confirmed, and either sphericity was maintained or the 
Box correction factor was used in reporting statistical output. 
I constructed a multivariable ANCOVA model to assess the relationship between the type 
of care management received (classified as either standard or intensive care management) and, 
separately, mean change in HbA1c, systolic blood pressure, diastolic blood pressure, and PCP 
visits. Variables assessed for potential confounding included: age, gender, race/ethnicity, and 
marital status. All variables were included in the fully adjusted model. Only variables that 
changed the coefficient of the independent variable within the fully adjusted model by more than 
10% were included within the reduced model for each separate relationship assessed. The 
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RESULTS (tables in Appendix E) 
Patient Characteristics 
Table 7 (Appendix E) summarizes the characteristics of the 146 patients included in the 
analysis. Patients are counted and described within two groupings contingent on the care 
management program received (ICM or SCM). Ages were similar with 51.9 and 51.2 years being 
the mean age for the ICM and SCM groupings, respectively (P=0.78). Females patients were 
predominant in both groups with no significant association found between gender and care 
management grouping (P=0.62).  
Overall, patients within the care management groups were most dissimilar by 
race/ethnicity, marital status, and chronic disease diagnosis. The groups had some racial 
dissimilarities with 43.5% of ICM patients identifying as Hispanic, while only 24.4% in the 
SCM did so. The proportion of black patients in each group was similar with 43.5% identifying 
as black in the ICM group and 50.4% in the SCM group. Despite these characteristics, there was 
no significant association indicated between race/ethnicity and care management grouping 
(P=0.19). Single persons accounted for 56.9% of the SCM and only 34.8% of the ICM group and 
married persons made up 21.1% of the SCM group compared to 34.8% of the ICM group 
(P=0.07). With respect to chronic disease diagnoses, 82.6% of the ICM group and only 32.5% of 
the SCM group had type 2 diabetes (P<0.05), 78.3% of ICM and 89.4% of SCM had 
hypertension (P=0.14), and 60.9% of the ICM and 22.0% of the SCM group had both diagnoses 
(P<0.05).  
ICM and SCM patients also differed in baseline HbA1c, PCP utilization, and diastolic 
blood pressure values, but were similar in systolic blood pressure values. The ICM group had a 
significantly higher baseline HbA1c at 10.6 ± 2.44 compared to 6.73 ± 1.48 (P>0.05) within the 
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SCM group. With respect to PCP visits during the baseline period, 91.3% of ICM versus 95.9% 
of SCM patients had a PCP visit (P=0.34). The median quantity of of PCP visits for each group 
was at 2 (IQR=2, P=0.20). Mean diastolic BP values for ICM patients were lower than those in 
SCM, with values of 81.5 ± 11.2 and 85.8 ± 10.8 (P=0.078), respectively. However, the ICM 
group had a similar mean systolic BP value of 141.6 ± 19.1 to that of the SCM group, 143.5 ± 
21.2 (P=0.69). 
Care management encounters 
There was a significant difference (P<0.05) in the number of phone encounters made 
with ICM patients (median=7; IQR=8) and SCM patients (median=2; IQR=3), as seen in Table 8 
(Appendix E). Home and community encounter counts were too low to register a median above 0 
(IQR=0). However, the proportion of patients receiving any in-home encounter was 17.4% 
among ICM patients and 2.44% among SCM patients (P=0.002), while the proportion of those 
receiving any community/practice encounters was 13.0% and 7.32% among ICM and SCM 
groups, respectively (P=0.36). 
Diabetes control 
Table 9 (Appendix E) shows the change in HbA1c pre- and post-care management 
participation. ICM patients showed a large, but non-significant decrease in HbA1c from 10.6 ± 
2.44 to 9.51 ± 2.80 (t=1.73, P=0.10). The repeated measure ANOVA showed a non-significant 
difference in group pre- and post-intervention means (F=3.0, P=0.10). The SCM group showed 
almost no change in HbA1c (6.73 ± 1.48 to 6.78 ± 1.31, P=0.92) and no change in pre-post 
means (F=2.01, P=0.166).  
Hypertension control  
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Systolic blood pressure decreased among those receiving ICM from 141.6 ± 19.1 to 137.2 
± 18.6 (t=1.43, P=0.168; F=0.204, P=0.168) as seen in Table 11 (Appendix E), but the decrease 
was non-significant. There was a similar non-significant decrease in systolic blood pressure 
among the SCM group (t=1.73, P=0.086; F=1.76, P=0.188).  
There were also non-significant decreases in the pre-post diastolic values for the ICM 
(t=0.536, P=0.598; F=0.29, P=0.598) and SCM (t=1.44, P=0.153; F=1.49; P=0.225) groups 
(Table 13, Appendix E).  
Primary care physician utilization  
Patients receiving SCM showed a statistically significant decrease in number of PCP 
visits (z=4.012, P<0.05) as shown in Table 15 (Appendix E). While number of PCP visits in 
patients receiving ICM showed no significant change with a median of 2 (IQR=2) for both pre 
and post-intervention visits (P=0.25). Overall, the proportion of ICM patients having any PCP 
visits in the period before and the period after receiving care management decreased from 91.3% 
to 82.6%, while it decreased even further from 95.9% to 72.4% among those receiving SCM.  
Difference in dependent variables among SCM and ICM groups 
Diabetes control 
Across groups, the unadjusted average decrease in HbA1c was 1.12 % (-1.96, -0.26; 95% 
CI) among ICM patients and a 0.02% (-0.56, 0.60: 95% CI) increase in HbA1c among SCM 
patients did not show a significant difference (P=0.11), as depicted in Table 10 (Appendix E). 
When adjusted for marital status (the only confounder in the reduced model), ICM patients 
showed an average 0.90% (-1.73, -0.08: 95% CI) decrease in HbA1c while those in SCM 
showed a smaller HbA1c decrease of 0.078% (-0.63, 0.48; 95% CI). The comparison of these 
mean changes remained statistically non-significant (P=0.11). 
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Hypertension control 
 Table 12 (Appendix E) shows the unadjusted mean change in systolic BP was a 5.55 (-
13.1, 2.0; 95% CI) point decrease among those in ICM and a 2.89 (-6.16, 0.38; 95% CI) point 
decrease among those in SCM, the difference between these mean changes was non-significant 
(P=0.53). When adjusted for race and marital status, the mean change in systolic BP among ICM 
patients was reduced to 4.81 (-12.35, 2.75; 95% CI) points and increased to 3.03 (-6.29, 0.23; 
95% CI) points for those in SCM. The difference in mean systolic BP change in the adjusted 
model remained non-significant (P=0.67). 
 The model showing the unadjusted mean change in diastolic BP found a 1.68 (-6.17, 
2.79; 95% CI) point decrease among ICM patients and a 1.30 (-3.24, 0.64; 95% CI) decrease 
among those in SCM, as seen in Table 14 (Appendix E). The unadjusted mean changes showed 
non-significant differences (P=0.88). Within the fully adjusted model—in this case, accounting 
for age, race, gender, and marital status—the mean change in diastolic BP for ICM showed a 
slight change with a 1.70 (-6.15, 2.75; 95% CI) mean decrease and no change for those in SCM 
with a 1.30 (-3.22, 0.62; 95% CI) decrease. The adjusted model continued to show a non-
significant difference between mean changes in diastolic BP among the groups (P=0.87). 
Primary care physician utilization  
Across groups, there was a non-significant difference in mean change in number of PCP 
in both the unadjusted (P=0.98) and the fully adjusted models (P=0.98) (Table 16, Appendix E). 
Care management goal achievement 
 Among the SCM group, 78.2% of patients achieved their care management goals 
compared to 57.1% of ICM patients (Table 17, Appendix E). 
 
  25 
DISCUSSION 
This evaluation of the PADC-LATCH care management program on the basis of health 
outcomes and PCP utilization shows overall mixed results. The hypothesis was that there would 
be no change in clinical outcomes or PCP utilization. These results only partially refuted that 
hypothesis since results were largely statistically non-significant, but clinically relevant. A 
review of patient characteristics reveals that individuals with the highest baseline HbA1c values 
were enrolled in ICM, indicating that diabetic patients most in need of an intensive care program 
were more likely to be receiving ICM. The opposite was true with respect to BP values, 
however. Patients enrolled in SCM had the highest mean systolic and diastolic BP values. This is 
not the expected result since the ICM protocol seeks to enroll very ill patients with diabetes 
and/or hypertension. There is an expectation that patients receiving ICM would have worse 
clinical statuses. This could be due to patients with complicated diabetes having more severe and 
immediate reasons to access to ICM compared to a stable patient with asymptomatic 
uncontrolled hypertension.  
Care management encounter data shows that ICM patients received significantly more 
phone encounters compared to their SCM counterparts. This is in addition to a greater proportion 
of ICM patients receiving home and community/practice encounters. These data are consistent 
with the expectation that ICM patients receive at least 3 care management encounters over the 3-
month protocol period and that SCM patients receive less care than ICM. This is evidence that 
the protocols are being properly administered to ICM and SCM patients.  
There was a substantial HbA1c reduction from to pre- to post-care management 
participation among those receiving ICM which is clinically relevant given that this group has a 
worse clinical status at baseline. The ICM group had an acceptable baseline HbA1c and even 
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with the small increase in HbA1c, the group mean remained within an acceptable range. When 
controlled for marital status, there was no significant difference in HbA1c change between 
groups. The hypothesized result was that of no change in HbA1c, especially considering the 
small sample size of the ICM group and the difficulty of effecting changes in poor clinical 
statuses. Despite a lack of statistical significance (possibly due to small sample size), the 
reduction in HbA1c among ICM patients is a positive effect of this program.  
With respect to blood pressure, patients receiving ICM and SCM showed non-significant 
decreases in systolic and diastolic blood pressure. In both unadjusted and reduced models 
adjusted for race and marital status, there was no significant difference between groups for both 
systolic and diastolic blood pressure.. The ICM group had lower baseline BP values, but also had 
the largest mean reduction in both BP values among the groups (almost double the mean 
reduction in systolic BP and only a slightly greater reduction in diastolic BP), however, the 
ability to find statistical significance was limited by the small sample size in this group. These 
results show that the higher frequency of care management encounters had by ICM patients may 
lead to greater reductions in BP compared to SCM. These results are encouraging in showing a 
slight positive effect on patient health outcomes. 
 An increase in PCP visits paired with a decrease in emergency department and/or or 
urgent care use was the expected medical use pattern for both groups, since they have high 
medical need. However, there is also a possibility that a reduction in PCP utilization could be 
desired for those who are accessing care too frequently without a valid medical need. In this 
analysis, PCP utilization decreased to a significant degree only in the SCM group, with an 
overall mean reduction in number of PCP visits in both groups. There was no significant 
difference between groups even when adjusted for all potential confounders. Similar high 
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proportions of ICM and SCM patients visited a PCP before receiving care management and both 
post-care management proportions of patients visiting a PCP decreased. However, the SCM 
group had the largest reduction in patients seeing a PCP post-care management at all.  
The reduction of PCP visits among both groups may attributed in part to the following 
reasons. Most uninsured patients in this evaluation access care at an FHQC. PCPs at this 
particular FHQC could be accessed free-of-charge until the fall of 2014, when a minimum 
payment system was installed. Either some or most of the decrease in the PCP utilization may be 
explained by this since all patients being served by these programs are low-income and may have 
found it more difficult to access primary care once it had a monetary cost attached. The decrease 
in PCP utilization could also be secondary to patients continuing to access the health care 
systems through avenues other than their PCP, i.e. emergency departments or urgent care 
centers. The larger decrease in the proportion of patients accessing a PCP post-care management 
in the SCM group may be explained by the reasons noted above and because SCM patients may 
have less medical problems and less severe disease complications that do not require as much 
PCP follow-up as a more ill and medically complex ICM patient may otherwise need.  
 Care management goals were achieved at a significantly higher rate by SCM individuals. 
The desired result would be that of having ICM patients achieve care management goals with 
same frequency as SCM. However, there is the possibility of ICM patients having more 
appointments to keep, more disease control goals, and more significant psychosocial barriers that 
make care management goals more difficult to achieve when compared to their less medically 
and psychosocially complex counterparts. Since ICM patients are receiving more care encounters 
than those in SCM and still achieving care management goals at a lower rate, this suggests that 
ICM patients may require more care encounters to achieve goals at the same rate. 
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The intended effect of PADC-LATCH care management programs is to improve patient 
efficacy and self-management skills to improve health outcomes and appropriate utilization of 
the healthcare system. The results of this evaluation of these care management programs indicate 
that both ICM and SCM programs are appropriately providing care management as seen through 
the most ill patients being enrolled in ICM and receiving more care encounters than SCM 
patients. Supporting goal achievement and improving clinical status as measured through 
decreased HbA1c and decreased BP values. However, goal achievement was lower in the ICM 
group suggesting that ICM patients require even more care management to achieve goals at the 
same rate. PCP utilization decreased for both groups and may have been most affected by 
external factors and not by the care management received. Given the collection of results, there 
is evidence that both programs are producing positive and clinically relevant, albeit not 
statistically significant, results. As such, there is an indication for the care management programs 
to be modified and improved so that clinical status, goal achievement, and PCP usage are able to 
improve to greater degrees.  
Comparison to other studies 
 The results of this analysis are somewhat similar to the results from similar studies. Kim 
et al. (2014) and Hebert et al. (2011) showed statistically significant improvements in pre-post 
blood pressure values for patients enrolled in nurse-led care management interventions. The 
Sekhobo, et al. (2008), Jovanovich et al. (2004), and Philis-Tsimakas et al.(2004) investigations 
all found reductions in pre- and post-care management HbA1c values, similar to the reductions 
found in this analysis. However, these 5 studies all found some degree of statistical significance 
in their health outcome improvements, whereas this evaluation did not yield any statistically 
significant improvement in HbA1c or blood pressure values.  
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Limitations 
There were some limitations to this evaluation. The retrospective design of this data 
analysis creates selection bias since patients were not randomized and the baseline patient 
characteristics were dissimilar.  There was a relatively small sample that participated in the ICM 
component, which means that the results from the sample may have limited generalizability and 
limited power. Lastly, the large time period allotted for adequate collection of HbA1c and blood 
pressure values may bias the results away from the null. It would be difficult to separate what 
effects on health outcomes were a result of the care management or a result of other factors, 
including time. 
Conclusions 
Despite the potential for biases in this evaluation, it shows weakly positive, but clinically 
relevant results. Both groups have their merits in improving in a few categories: patients in the 
ICM group showed large reductions in HbA1c and systolic BP, while patients in SCM showed 
modest reductions in BP values and a rate of goal achievement. However, larger reductions in 
HbA1c and BP values paired with higher goal achievement and improved PCP utilization are 
goals for each program. As such, a recommendation to modify the care management protocol for 
each group to address deficiencies in improving HbA1c, BP values, goal achievement, and 
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APPENDIX 
Appendix A: Table 1-Type 2 DM and hypertension statistics by race and poverty level 








Diabetes prevalence (CDC, 2014) (%) 13.2 12.8 7.6 
Mortality rate attributed to type 2 DM 





male-24.3               
female-16.2 
Hypertension prevalence (Yoon et al., 
2015) (%) 41.2 25.9 28 
Mortality rate attributed to 
hypertension (Mozaffarian et al., 2015) 




male-17.6               
female-15.2 
Living below the poverty line 
(DeNavas-Walt & Proctor, 2015) (%) 26.2 23.6 10.6 
Incidence of ESRD associated with 
diabetes (CDC’s Division of Diabetes 
Translation-National Center for 
Chronic Disease Prevention and 
Health Promotion, 2013a) (per 100 000 
people) 461.7 271.8 170.7 
Percentage of adults with diagnosed 
diabetes reporting visual impairment 
(CDC’s Division of Diabetes 
Translation-National Center for 
Chronic Disease Prevention and 
Health Promotion, 2013b) (%) 20.7 15.6 17.1 
Percentage of adults 35 and older with 
diagnosed diabetes reporting heart 
disease or stroke (CDC’s Division of 
Diabetes Translation-National Center 
for Chronic Disease Prevention and 
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Local Access to Coordinated Healthcare (LATCH)-Project Access of Durham County (PADC)
Pre/Post Appointment Follow-up Protocol
Enters	referral	 into	COACH







LATCH	Care	Manager	initiates	telephone	 contact	 1-5	days	pre-appointment	 to:
Ø review	dates	of	upcoming	specialty	appointment(s)
Ø review	appointment	 prep	information	 	(endoscopy/colonoscopy)
Ø assess/address	barriers	 and	provide	 care	coordination	 needs
Documents	 referral	reason(s)	and	need	for	intensive	care	management
LATCH	Care	Manager	initiates	telephone	 contact	 within	 5-10		days	post-
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Local Access to Coordinated Healthcare (LATCH)-Project Access of Durham County (PADC)
Chronic Disease Management Protocol for Chronic Diseases related to 
Specialty Care Consultation and/or Out-of-Control and a Barrier to Treatment
1 chronic disease
LATCH Health Education Specialist
2 or more chronic diseases

























ü Patient	education:	 conduct	 education	 about	disease	and		self-management	
strategies		
ü Medication	Adherence:	 	review	medications	 and	address	barriers	 to	adherence	
ü Self-management	goals:	set	goals	for	30	days
ü PCP	Utilization:	 promote	 consistent	 PCP	use
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LATCH	Care	Manager	conducts	bi-weekly		phone/home	visit	for	6	weeks	to	assess:	
ü follow-through	 on	PCP	and	other	 referrals
ü progress	on	self-management	goals
ü barriers	 to	meeting	goals	and		care	coordination	 needs
LATCH	Care	Manager	conducts	3-month	 	telephone	 contact	 to	assess:		
ü follow-through	 on	PCP	and	other	 referrals






Local Access to Coordinated Healthcare (LATCH)-Project Access of Durham County (PADC)
Chronic Disease Management Protocol for Chronic Diseases related to 
Specialty Care Consultation and/or Out-of-Control and a Barrier to Treatment
(continued)
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Appendix C: Figure 4-PUBMED search strategy 
 
1. "adult" [Mesh] OR "middle aged adults"[tiab] OR "young adults"[tiab] OR "aged"[tiab] 
OR "elderly"[tiab]  
a. (Results: 6164023) 
2. "disease management"[Mesh] OR "care management"[tiab] OR "intensive care 
management"[tiab] or "case management"[tiab]  
a. (Results: 59508)  
3. "diabetes mellitus, type 2"[Mesh] OR "diabetes type 2"[tiab] OR "type 2 diabetes 
mellitus"[tiab] OR "adult onset diabetes mellitus"[tiab] OR "non-insulin dependent 
diabetes mellitus"[tiab]  
a. (Results: 108069) 
4. "hypertension"[Mesh] OR "high blood pressure"[tiab]  
a. (Results: 229654) 
5. (("diabetes mellitus, type 2"[Mesh] OR "diabetes type 2"[tiab] OR "type 2 diabetes 
mellitus"[tiab] OR "adult onset diabetes mellitus"[tiab] OR "non-insulin dependent 
diabetes mellitus"[tiab]))) OR (("hypertension"[Mesh] OR "high blood pressure"[tiab]) 
a. (Results: 330366) 
6. ((("adult" [Mesh] OR "middle aged adults"[tiab] OR "young adults"[tiab] OR 
"aged"[tiab] OR "elderly"[tiab]))) AND (("disease management"[Mesh] OR "care 
management"[tiab] OR "intensive care management"[tiab] or "case management"[tiab]))) 
AND (((("diabetes mellitus, type 2"[Mesh] OR "diabetes type 2"[tiab] OR "type 2 
diabetes mellitus"[tiab] OR "adult onset diabetes mellitus"[tiab] OR "non-insulin 
dependent diabetes mellitus"[tiab]))) OR (("hypertension"[Mesh] OR "high blood 
pressure"[tiab]))  
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Appendix C: Table 2-Study characteristics  
 








hypertension Low-income/uninsured patients Age, yr, mean ± SD 









management No Yes 
Yes; Family income below 120% of 
minimum living costs 
85% were older than 
65 years 






program Yes No 
Yes; predominantly low-income, minority 
population receiving care at a multisite 
community health center 
3 groups based on A1c 
control: Good-62.4 ± 
14.4, Intermediate-
61.4 ± 12.7, Poor-58.7 
± 11.2 
California 
Medi-Cal Type  
2 Diabetes 
Research 




case management Yes No 
Yes; study conducted at clinical sites 
serving low-income Medi-Cal populations 
Intervention: 57.0 ± 
0.9. Control: 56.9 ± 
1.0. 







intervention No Yes 
Yes; patients recruited from highly diverse 
urban Harlem, New York neighborhood 
and from a FQHC. However, risk of other 
patients being included since low income 
or uninsurance was not an explicit criteria 
for eligibility. 
Nurse group: 60.5 
±11.1. Usual care: 
61.2 ±12.0. BP 
monitor: 61.3 ±11.7. 
Usual care: 61.0 
±11.8. 
Philis-Tsimikas 






education Yes No 
Yes; patients belonged to one of 3 low-
income payer groups: Medi-Cal, 
Medically Indigent Adult (MIA) health 
services program, or uninsured and 
income under the appropriate federal 
poverty level.  
Intervention: 51 ± 
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Appendix C: Table 3-Study characteristics, continued 
Study 
# of 





encounter Eligibility criteria Exclusion criteria 
Kim et al, 2014 22 
Community-based  case management: 1. Selection 
of participants, 2. Needs assessment, 3. 
Prioritization of problems and planning case 
management, 4. Implement case management 





1. 30 years or older, newly 
diagnosed with hypertension per 
JNC-7 or taking anti-hypertensive 
medications, 3. Within lowest 
50% of health insurance level, 4. 
Income below 120% of minimum 
living standards 
None identified; 2 patients 
excluded due to excessive 
missing data 
Sekhobo et al, 2008 132 
Case managers provide diabetes education and self-
management support to patients, link patients to 




Patients with type 2 diabetes 
active in 2002, with follow-up 
visits in the study period. 
Patients missing data on key 
variables were excluded. 
California Medi-Cal Type  
2 Diabetes Research 
Group, 2004 362 
1. Adherence to EBM practice guidelines for 
diabetes medication, 2. Identification of barriers to 
care, and plans to address barriers, 3. Glucometer 
and education on use, 4. Diet, exercise, and diabetes 
self-management education. (Interactions were in-
home or telephonic encounters, as needed). 
4 years 
(7/1/1195-
6/30/1999) As needed HbA1c levels greater than 7.5% 
Patients missing HbA1c 
data 
Hebert et al., 2012 416 
Nurse management-1. Face-to-face counseling to 
improve self-care behaviors, 2. Counseling on 
reducing making and alcohol intake, 3. Regular 
telephone follow-up, 4. Nurse and physician 
communication about patient treatment plan.  Home 
BP monitor intervention-1. Receive BP monitor, 
information on use, and no nurse follow-up.  9 months Unclear 
1. 18 years or older, 2. Living 
within community at time on 
enrollment, 3. Receiving care for 
at least 6 months at clinical site, 4. 
uncontrolled hypertension 
recorded in their last two visit 
notes, 5. BP >=150/95 at 
recruitment. 
1. Pregnancy, 2. renal 
dialysis, 3. terminal illness, 
4. blindness, deafness, or 
cognitive impairment. 
Philis-Tsimikas et al., 
2004 153 
Nurse-led management-1. 2-hour baseline visit, 2. 
Subsequent clinic visits reviewed self-management, 
guidelines, and goals along with medication 
changes. A minimum of 4 clinic visits with nurses 
was advised. Peer education component-1. Peer 






4 nurse visits 
per year 
advised. 
1. Diagnosis with either type 1 or 
type 2 diabetes, 2. Aged 18-80, 3. 
Belongs to one of 3 payer groups: 
Medi-Cal, Medically Indigent 
Adult (MIA) health services 
program, or uninsured and income 
under the appropriate federal 
poverty level.  
1. Diabetes in pregnancy, 2. 
severe medical conditions 
precluding consistent 
attendance to clinic, 3. 
Anticipated death in less 
than 2 years, 4. serum 
creatinine >3.5 mg/dL, 5. 
Active alcohol or drug 
abuse, 6. Lack of permanent 
residency in San Diego 
County.  
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Appendix C: Table 4-Study characteristics, continued 




follow-up Outcomes measured Sources of conflict 
Kim et al, 2014 
None; patients served as 
controls within pretest-
post-test design 
Public health center 
in Seoul serving a 
population of 




management, 3. Blood 
pressure control 
None listed and none 
identified. 
Sekhobo et al, 2008 
Control clinic belongs to 
same network as study 
clinic but does not have 
case management  
Multisite community 
health center 
Case managers specially 






First author employed as 
research scientist at New York 
State Dept. of Health, second 
author was medical director of 
Open Door Family Clinic. No 
additional COIs identified.  
California Medi-Cal Type  2 
Diabetes Research Group, 
2004 
Control group was 
randomized at each of the 
3 clinical sites 
Three clinical sites 
serving Medi-Cal 
patients in Santa 
Barbara, Los 
Angeles, and San 
Diego. One was 
community-based, 




endocrinologist at each 
site.  
Mean duration of 
follow-up was 25.3 
months 
Glycemic control, 
measured by HbA1c. 
None listed. However, the 
California Medi-Cal Managed 
Care Division and CDC 
funded the study, potential for 
overestimate of care 
management effect.  
Hebert et al., 2012 
Usual care-Received BP 
pamphlet and regular 
visits with clinician.  
Federally Qualified 
Health Center and 
four hospitals in 
Harlem, New York.  Nurses 18 months 
Primary outcome-BP 




were measured via 
surveys.  
None disclosed, however study 
was funded, in part, by NIH-
National Center for Minority 
Health and Health Disparities 
which may lead to an implicit 
bias that may overestimate 
effect of nurse management 
intervention. 
Philis-Tsimikas et al., 2004 Usual care 
Six clinical sites 
across San Diego 
County 
Nurse-led team 
consisting of RN/certified 
diabetes educator, 
medical assistant, and 
dietitian.  1 year 
Outcomes in HbA1c, 
BP, lipids, BMI, 
patient satisfaction 







companies listed as funders or 
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Appendix C: Table 5-Risk of bias for included studies 
Study  Study design Random sequence generation Allocation concealment Similar baseline characteristics 
Kim et al., 2014 
Prospective cohort study, "single 
group pretest-post-test" 
Low risk of bias-No sequence 
generation, all patients were 
given the same intervention. 
Low risk of bias-Patients were openly 
informed, consented, and enrolled in 
the intervention. 
High risk of bias-86.4% were older than 65 
years, 77.3% were female, and 59% lived 
alone.  
Sekhobo et al., 2008 Retrospective cohort study 
Low risk of bias-No sequence 
generation because of 
retrospective design and all 
patients at study clinic were 
given intervention so no 
selective enrollment. 
Low risk of bias-No random sequence 
generated, so now concealment 
needed. All patients at study clinic 
were given intervention. 
High risk of bias-Only 29 subjects in 
control group compared to 103 in in study 
group.  
California Medi-Cal Type  2 
Diabetes Research Group, 2004 Randomized, controlled study 
Low risk of bias-Computer-
generated time-blocked 
allocation sequence was used 
for randomization at each of the 
3 clinical sites.  
Low risk of bias-Allocation was 
concealed using sequentially labeled 
sealed envelopes. 
Low risk of bias-Groups were similar at 
baseline, no exceptional differences exist.  
Hebert et al., 2012 
Randomized controlled 
effectiveness trial 
Low risk of bias-Computer-
generated random-number 
sequence without blocking or 
stratification for randomization 
Low risk of bias-concealment through 
sealed opaque envelopes. 
Low risk of bias-All 3 groups were similar 
at baseline. The only exception was a 
greater proportion of patients with 
depression in the BP monitor group (25.8%) 
compared to usual care (14.7%) 
Philis-Tsimikas et al., 2004 Prospective cohort study 
High risk of bias-The first 310 
patients referred to the program 
were enrolled into the 
intervention arm. All patients 
referred thereafter were 
relegated to the usual care arm.  
High risk of bias-No randomization, so 
no allocation of treatment group.  
Low risk of bias-Groups were similar at 
baseline across gender, age, ethnicity, 
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Appendix I: Table 6-Risk of bias for included studies, continued 




Blinding of outcome 
assessors Selective outcome reporting Other bias 
Kim et al., 2014 
Low risk of bias-Only 2 
withdrawals due to excessive 
missing data. Cross-overs were not 
possible with this study. 
Adherence issues were not noted.  
High risk of bias-Risk 
of performance bias 
due to lack of blinding 
of these two groups 
and the open 
knowledge of being 
involved in a study. 
Low risk of bias-No note of 
this blinding, however since 
all patients were given the 
same intervention and there 
are no groups being 
compared, there is a low risk 
of detection bias.  
Low risk of bias-this was not 
discussed by the authors, 
however all outcomes reported 
in methods were reported in 
results 
High risk of bias-small sample 
size, lack of control group. 
Sekhobo et al., 2008 
Low risk of bias-Only 6 of 138 
eligible patients were excluded due 
to missing data on key variables. 
No withdrawals due to study 
design.  
Low risk of bias-Not 
needed since study was 
not ongoing at time of 
intervention.  
High risk of bias-No note of 
assessor blinding, this may 
lead to detection bias since 
there was a study and control 
group being compared.  
Low risk of bias-not discussed, 
but all discussed outcomes 
were reported in results. 
Low risk of bias-no other 
potential for bias identified 
California Medi-Cal Type  2 
Diabetes Research Group, 
2004 
Low risk of bias-15 patients were 
lost to follow-up in the 
intervention group, and 26 patients 
were lost to follow-up in the 
control group. No withdrawals or 
cross-overs were noted, but 
analysis was performed with 
intention-to-treat to minimize bias.  
High risk of 
performance bias-
HbA1c values were 
available to both 
groups. Blinding of 
either group was 
impossible given 
nature of intervention.  
High risk of bias-No mention 
of blinding of outcome 
assessors, which leads to 
potential for bias given that 
an intervention and control 
group are being compared.  
Low risk of bias-the primary 
outcome of HbA1c was 
reported on in addition to 
numerous secondary outcomes.  
Low risk of bias-no other 
potential for bias identified 
Hebert et al., 2012 
Low risk of bias-49 of 176 people 
were lost to follow-up in the usual 
care arm, 32 of 120 in the BP 
monitoring group, and 35 of 120 in 
the nurse management group. 
However, there was a similar rate 
of attrition in each group and 
analysis was done with multiple 
imputation to account for missing 
data, so risk of bias is lowered.  
High risk of bias-
Given the nature of the 
interventions it is 
difficult to blind 
participants and 
personnel. This leads 
to potential for 
performance bias.  
Low risk of bias-Study 
personnel recording BPs 
were blinded to patient 
assignment 
Low risk of bias-Not 
mentioned by authors, but 
primary outcome of BP at 9 
months was recorded and 
examined.  
High risk of bias-unorthodox 
recruitment in which study 
began as a 2-arm trial (nurse 
and usual care groups) and 
once further funding was 
secured was expanded to 3-
arms to included home BP 
monitoring. Limitation 
discussed, especially effect on 
controls, but this may still 
provide biased results.  
Philis-Tsimikas et al., 2004 
High risk of bias-Only 153 of the 
original 310 patients recruited 
completed the intended study 
duration. Statistical analysis did 
not account for this attrition.  
High risk of bias-No 
blinding of either 
group and both parties 
knew that a study was 
ongoing. 
High risk of bias-No note of 
outcome assesssors being 
blinded, with 2 groups being 
compared, there is a high risk 
of detection bias.  
Low risk of bias-not discussed, 
but all intended outcomes were 
reported.  
Low risk of bias-no other 
potential for bias identified 
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Appendix E: Table 7-Patient characteristics 
  Care Management Received   
  ICM (comparison group) SCM (referent group) P 
Sample size (n)(%) 23 (15.8) 123 (84.2)   
Age (years)    
0.78 Mean (SD) 51.9 (8.63) 51.2 (10.4) 
        
Gender    
0.62 
Male (%)  39.1 44.7 
Female (%) 60.9 55.3 
        
Race/Ethnicity    
0.19 
Black (%) 43.5 50.4 
Hispanic (%) 43.5 24.4 
White (%) 13 17.1 
Other (%) 0 8.13 
        
Marital Status    
0.07 
Single (%) 34.8 56.9 
Married (%) 34.8 21.1 
Divorced (%) 26.1 11.4 
Other (%) 4.4 10.6 
    
Type 2 diabetes diagnosis (%) 82.6 32.5 0 
Hypertension diagnosis (%) 78.3 89.4 0.14 
Type 2 diabetes and hypertension 
diagnoses (%) 60.9 22.0 0 
Baseline Hgb A1c (SD) 10.6 (2.44) (20 obs) 6.73 (1.48) (56 obs) 0 
        
Baseline Systolic BP (SD) 141.6 (19.1) (23 obs) 143.5 (21.2) (122 obs) 0.69 
        
Baseline Diastolic BP (SD)  81.5 (11.2) (23 obs) 85.8 (10.8) (122 obs) 0.078 
        
PCP visits (pre-care 
management) (IQR) 2 (2) 2 (2) 0.2 
    
Patients having a PCP visit 
during baseline period (%) 
 91.3 95.9 0.34 
    
Data compiled by myself. Key: SD, standard deviation; ICM, intensive care management; SCM, standard care management; HbA1c, hemoglobin 
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Appendix E: Table 8-Care management encounters 
  Care Management Received   
  ICM SCM P 
Sample size (n) 23 123   
CM phone encounters (IQR) 
7 (8) 2 (3) 
0 
CM In-home encounters (IQR) 
0 (0) 0 (0) 
0.002 




CM community/practice encounter (IQR) 0 (0) 0 (0) 0.36 





Data compiled by myself. Key: ICM, intensive care management; SCM, standard care management; CM, care management; IQR, interquartile 
range. Statistical significance set at P<0.05. 
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Appendix E: Table 9-Change in hemoglobin A1c 
  Care Management Received   
  ICM SCM P 
Sample size (n) 23 123   
     
0 
Baseline HbA1c 
(SD) 10.6 (2.44) (20 obs) 6.73 (1.48) (56 obs) 
     
0.004 
Follow-up HbA1c 
(SD) 9.51 (2.80) (20 obs) 6.78 (1.31) (58 obs) 
      
t-statistic 1.73 -0.096  
P 0.1 0.923   
      
F-statistic 3 2.01  
df 20 65  
P 0.1 0.166   
     
0.11 
Change in HbA1c 
(SD) -1.12 (2.81) 0.02 (1.30) 
     
0.09 % change in HbA1c  -8.76 2.03 
 
Data compiled by myself. Key: SD, standard deviation; ICM, intensive care management; SCM, standard care management; HbA1c, hemoglobin 
A1c; df, degrees of freedom. Comparisons were made by paired t-test (reported with t-statistic), Wilcoxon signed-rank test (z-statistic), or 
repeated measures one-way ANOVA (F-statistic). Statistical significance set at P<0.05.  
 
 




change in HbA1c 
(95% CI) P 
Fully adjusted mean 
change in HbA1c1 
(95% CI) P 
Adjusted mean 
change in HbA1c2  
(95% CI) P 
Standard 0.02 (-0.56, 0.60)  0.04 -0.06 (-0.63, 0.50) 0.1 -0.078 (-0.63, 0.48) 0.11 
Intensive -1.12 (-1.96, -0.26) -0.94 (-1.78, -0.09) -0.90 (-1.73, -0.08) 
Data compiled by myself. Key: HbA1c, hemoglobin A1c; CI, confidence interval. 1. Adjusted for age, gender, race, and marital status. 2. 
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Appendix E: Table 11-Change in systolic blood pressure 
  Care Management Received   
  ICM SCM P 
Sample size (n) 23 123   
     
0.69 Baseline Systolic BP (SD) 141.6 (19.1) (23 obs) 143.5 (21.2) (122 obs) 
     
0.43 Follow-up Systolic BP (SD) 137.2 (18.6) (22 obs) 140.6 (18.9) (118 obs) 
      
t-statistic 1.43 1.73  
P 0.168 0.086   
      
F-statistic 2.04 1.76  
df 22 113  
P 0.168 0.188   
     
0.53 Change in Systolic BP (SD) -5.55 (18.2) -2.89 (18.0) 
     
0.46 % change in Systolic BP -3.18 -1.15 
Data compiled by myself. Key: SD, standard deviation; ICM, intensive care management; SCM, standard care management; BP, blood pressure; 
df, degrees of freedom. Comparisons were made by paired t-test (reported with t-statistic), Wilcoxon signed-rank test (z-statistic), or repeated 
measures one-way ANOVA (F-statistic). Statistical significance set at P<0.05.  
 
 




change in systolic 
BP (95% CI) P 
Adjusted mean 
change in systolic 
BP1 (95% CI) P 
Adjusted mean 
change in systolic 
BP2 (95% CI) P 
Standard -2.89 (-6.16, 0.38) 
0.53 
-3.01 (-6.25, 0.24) 
0.65 
-3.03 (-6.29, 0.23)       
0.67 
Intensive -5.55(-13.10, 2.00) -4.90 (-12.43, 2.62) 
-4.81 (-12.35, 
2.75)           
Data compiled by myself. Key: BP, blood pressure; CI, confidence interval. 1. Adjusted for age, gender, race, and marital status 2. Adjusted for 
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Appendix E: Table 13-Change in diastolic blood pressure 
 
Data compiled by myself. Key: SD, standard deviation; ICM, intensive care management; SCM, standard care management; BP, blood pressure; 
df, degrees of freedom. Comparisons were made by paired t-test (reported with t-statistic), Wilcoxon signed-rank test (z-statistic), or repeated 
measures one-way ANOVA (F-statistic). Statistical significance set at P<0.05. 
 
 




change in diastolic 
BP (95% CI) P 
Adjusted mean 
change in diastolic 
BP1 (95% CI) P 
Standard -1.30 (-3.24, 0.64) 0.88 
-1.30 (-3.22, 
0.62) 0.87  
Intensive -1.68 (-6.17, 2.79) 
-1.70 (-6.15, 
2.75) 
Data compiled by myself. Key: BP, blood pressure; CI, confidence interval. 1. Adjusted for age, gender, race, and marital status. Statistical 

















  Care Management Received   
  ICM SCM P 
Sample size (n) 23 123   
     
0.078 Baseline Diastolic BP (SD)  81.5 (11.2) (23 obs) 85.8 (10.8) (122 obs) 
     
0.1 
Follow-up Diastolic BP 
(SD)  79.8 (12.1) (22 obs) 84.5 (10.6) (118 obs) 
      
t-statistic 0.536 1.44  
P 0.598 0.153   
      
F-statistic 0.29 1.49  
df 22 107  
P 0.598 0.225   
     
0.91 
Change in Diastolic BP 
(SD) -1.69 (14.8) -1.31 (9.80) 
     
0.99 % change in Diastolic BP  -0.87 -0.89 
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Appendix E: Table 15-Change in primary care physician utilization 
  Care Management Received 
  
  ICM SCM P 
Sample size (n) 23 123   
     
0.2 
PCP visits (pre-care management) 
(IQR) 2 (2) 2 (2) 
     
0.052 
PCP visits (post-care management) 
(IQR) 2 (2) 1 (2) 
      
z-statistic 1.15 4.012  
P 0.25 <0.05   
     
0.98 Change in PCP visits (SD) -0.65 (2.04) -0.64 (1.66) 
     
0.39 % change in PCP visits -0.8 -16.7 
    
Patients having a PCP visit during 
baseline period (%) 
 91.3 95.9 
 
0.34 
    
Patients having a PCP visit during 
follow-up period (%) 
 82.6 72.4 
0.30 
    
Data compiled by myself. Key: SD, standard deviation; ICM, intensive care management; SCM, standard care management; PCP, primary care 
physician; IQR, interquartile range. Comparisons were made by paired t-test (reported with t-statistic), Wilcoxon signed-rank test (z-statistic), or 
repeated measures one-way ANOVA (F-statistic). Statistical significance set at P<0.05.  
 








change in PCP 
utilization1 (95% 
CI) P 
Standard -0.64 (-0.95, -0.34) 0.98 -0.64 (-0.94, -0.34) 0.98 
Intensive -0.65 (-1.35, 0.05) -0.65 (-1.35, 0.05) 
Data compiled by myself. Key: BP, blood pressure; CI, confidence interval. 1. Adjusted for age, gender, race, and marital status. Statistical 
significance set at P<0.05. 
 
Appendix E: Table 17-Care management goal achievement 
  Care Management Received   
  ICM SCM P 
Sample size (n) 23 123   
     
0.04 Achieved goals 57.1 78.2      
Did not achieve goals 42.9 21.8 
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